Iroferose Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Fe sucrose

Indications/Uses

Fe deficiency anemia in patients undergoing chronic hemodialysis who are receiving supplemental erythropoietin therapy.

Click to view Iroferose detailed prescribing information

Dosage/Direction for Use

Adult & elderly Individualized dosage. Max: 200 mg not >3 times/wk. IV drip infusion 5 mL (100 mg Fe) diluted soln in at least 15 min or 10 mL (200 mg Fe) in at least 30 min. Slow IV inj Rate: 1 mL (20 mg Fe) undiluted soln/min (ie, 5 min/amp) not exceeding 2 amp (200 mg Fe)/inj.

Click to view Iroferose detailed prescribing information

Overdosage

View Iroferose overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity. Anemias not attributable to Fe deficiency. Fe overload or disturbances in utilisation of Fe. Patients w/ history of asthma, eczema or other atopic allergy. Pregnancy (1st trimester).

Click to view Iroferose detailed prescribing information

Warnings

For additional cautionary notes to warn of the potential risk of using the medicine... Click to view Iroferose detailed prescribing information

Special Precautions

Periodic monitoring of hematologic & anti-anemia parameters (Hb, hematocrit, serum ferritin & transferrin saturation); w/held therapy in patients w/ evidence of Fe overload. Acute or chronic infection. Stop administration in patients w/ ongoing bacteremia. Hypotensive episodes if administered too rapidly. Allergic reactions, sometimes involving arthralgia. Avoid paravenous leakage. Avoid in patients w/ hepatic dysfunction where Fe overload is precipitating factor particularly porphyria cutanea tarda. Pregnancy & lactation. Not recommended in childn.

Click to view Iroferose detailed prescribing information

Use In Pregnancy & Lactation

Click to view Iroferose detailed prescribing information

Adverse Reactions

Transient taste perversion, hypotension, fever & shivering, inj site reactions & nausea.

Click to view Iroferose detailed prescribing information

Drug Interactions

Reduced absorption of oral Fe.

Click to view Iroferose detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Iroferose detailed prescribing information

Storage

View Iroferose storage conditions for details to ensure optimal shelf-life.

Description

View Iroferose description for details of the chemical structure and excipients (inactive components).

Action

View Iroferose mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Vitamins & Minerals (Pre & Post Natal) / Antianemics

ATC Classification

B03AC - Iron, parenteral preparations ; Used in the treatment of anemia

Regulatory Classification

Presentation/Packing

Form

Iroferose soln for inj 100 mg/5 mL

Packing/Price

5 mL x 5 × 1's

Iroferose

iron sucrose

Manufacturer:

Swiss Parenterals

Distributor:

New Marketlink

Marketer:

Ambica